Effect of Enrofloxacin on Histochemistry, Immunohistochemistry and Molecular Changes in Lamb Articular Cartilage
Enrofloxacin is a synthetic chemotherapeutic agent from the class of the fluoroquinolones that is widely used to treat bacterial infections. It is metabolized to ciprofloxacin in the body as active metabolite. Fluoroquinolones change in the articular cartilage, especially with high doses and more than two weeks use. So, due to relatively excessive use of enrofloxacin in mammals and similarity of lambs to human subjects with respect to skeletal activity cycles, this study was done to investigate the effects of enrofloxacin on some cellular and molecular changes in growing lamb articular cartilage to evaluate some possible mechanisms involved these changes. Twelve, 2-month-old male lambs divided into three groups: control group received only normal saline; therapeutic group received 5mg/kg enrofloxacin subcutaneously, daily, for 15 days and toxic group received 35 mg/kg enrofloxacin in the same manner as therapeutic group. Twenty four hours after the last dose, the animals were sacrificed, and their stifle joints were dissected. Sampling from distal femoral and proximal tibial extremities was done quickly for further histological and molecular studies. Collagen-п content was studied with avidin-biotin immunohistochemistry method in different groups. Expression of Sox9 and caspase-3 was evaluated by Real–time PCR. Immunohistochemical changes were included decreases of matrix proteoglycans, carbohydrates, and Collagen-п in the toxic group. Some of these changes were observed in the therapeutic group with less intensity in comparison to the toxic group. Enrofloxacin were significantly decreased (P≤0.05). Sox9 expression in therapeutic and toxic groups compared to control group. But caspase -3 expressions in the toxic group significantly increased (P≤0.0001) with a comparison to other groups, while, between control and therapeutic groups, there were no significant differences. So, it can be concluded that enrofloxacin increases apoptosis in chondrocytes and decreases their numbers. Enrofloxacin use in growing lambs even at recommended therapeutic dose is not completely safe on articular cartilage. Moreover, higher doses of enrofloxacin induce severe changes in lamb articular cartilage.
Hall M, Finnoff J, Smith J. Musculoskeletal complications of fluoroquinolones. PM R 2011;3(2):132-42.
Lim S, Hossain MA, Park J, et al. The effects of enrofloxacin on canine tendon cells and chondrocytes proliferation in vitro. Vet Res Comun 2008;32(3):243-53.
Adams HR, editor. Veterinary Pharmacology and Therapeutics. 8th ed. Ames, USA: Iowa State University Press, 2001: p. 900-5.
Maslanka T, Jaroszewski JJ, Mikolajczky A, et al. Effect of increasing doses of enrofloxacin on chicken articular cartilage. Pol J Vet Sci 2009;12(1):21-33.
Sendzik J, Lode H, Stahlmann R. Qunolone induced arthropathy, an update focusing on new mechanistic and clinical data. Int J Antimicrob Agents 2009;33(3):194-200.
Burkhardt JE, Hill MA, Carlton WW, et al. Histologic and histochemical changes in articular cartilages of immature Beagle dogs dosed with difloxacin, a fluroquinolone. Vet Pathol 1990;27(3):162-70.
Burkhardt JE, Hill MA, Turek JJ, et al. Ultrastractural changes in articular cartilages of immateure Beagle dogs dosed with difloxacin, a fluoroquinolone. Vet Pathol 1992;29(3):230-8.
Forster L, Kociok K, Shakibaei M, et al. Integrins on joint cartilage chondrocytes and alterations by ofloxacin or magnesium deficiency in immature rats. Arch Toxicol 1996;70(5):261-70.
Machida M, Kusajima H, Aijima H, et al. Toxicokinetic study of norfloxacin induced arthropathy in juvenile animals. Toxicol Appl Pharmacol 1990;105(3):403-12.
Bendele AM, Hulman JF, Harvey AK, et al. Passive role of articular chondrocytes in quinolone induced arthropathy in guinea pigs. Toxicol Pathol 1990;18(2):304-12.
Egerbacher M, Edinger J, Tschulenk W. Effects of enrofloxacin and ciprofloxacin hydrochloride on canine and equine chondrocytes in culture. Am J Vet Res 2001;62(5):704-8.
Yoon JH, Bryan J, Budsberg SC. The effect of enrofloxacin on cell proliferation and proteoglycans in horse tendon cells. Cell Biol Toxicol 2004;20(1):41-54.
Panda DK, Miao D, Hendy GN. The transcription factor sox9 regulates cell cycle and differentiation genes in chondrocytic CFK2 cells. J Biol Chem 2001;276(44):41229-36.
Sendzik J, Shakibaei M, Korting MS, et al. Fluoroquinolones cause changes in extracellular matrix, signaling proteins, metalloproteinases and caspase-3 in cultured human tendon cells. Toxicology 2005;212(1):24-36.
Sanson JM, Wilsman NJ, Leiferman EM, et al. The effect of fluroquinolone antibiotics on growing cartilage in the lamb Model. J Ped Orthop 2009;29(2):189-95.
Lillie RD, editor. Histopathologic technique and practical histochemistry. 3rd ed. New York: McGraw-Hill 1965: p.493.
Hollander AP, Pidoux I, Reiner A, et al. Damage to type II collagen in aging and osteoarthritis starts at the articular surface, originates around chondrocytes, and extends into the cartilage with progressive degeneration. J Clin Invest 1995;96(6):2859-69.
Ruettger A, Neumann S, Wiederanders B, et al. Comparison of different methods for preparation and characterization of total RNA from cartilage samples to uncover osteoarthritis in vivo. BMC Res Notes 2010;3(1):7.
Schaad UB. Use of quinolones in pediatrics. Eur J Cli Mic Inf Dis 1991;10(4):355-60.
Burkhardt JE, Forster C, Hill MA. Immunohisochemistry of articular cartilage from immature beagle dogs dosed with difloxacin. Toxicol Pathol 1997;25(5):475-80.
Buckwalter JA, Mankin HJ. Articular cartilage. part I: Tissue design and chondrocyte matrix interactions. Instr Course Lect 1998;47:477-86.
Deponti D, Giancamillo AD, Mangiavini L, et al. Fibrinbased model for cartilage regeneration: tissue maturation from in vitro to in vivo. Tissue Eng Part A 2012;18(11-12):1109-22.
Kafienah W, Mistry S, Perry MJ, et al. Pharmacological regulation of adult stem cells: chondrogenesis can be induced using a synthetic inhibitor of the retinoic acid receptor. Stem Cells 2007;25(10):2460-8.
Shintaini N, Hunziker EB. Differential effects of dexamethasone on the chondrogenesis of mesanchymal stromal cells: influence of microenvironment, tissue origin and growth factor. Eur Cells Mater 2011;22:302-20.
Sheng Z, Cao X, Wang C, et al. Ofloxacin induces apoptosis in microencapsulated juvenile rabbit chondrocytes by caspase- 8- dependent mitochondrial pathway. Toxicol Appl Pharmacol 2008;226(2):119-27.
Maslanka T, Jaroszewski JJ, Chrostowska M. Pathogenesis of Quinolone induced arthropathy a review of hypotheses. Pol J Vet Sci 2004;7(4):323-31.
Egerbacher M, Wolfesberger B, Walter I, et al. Integrins= mediate the effects of quinolones and magnesium deficiency on cultured rat chondrocytes. Eur Cell Biol 1999;78(6):391-7.
Corps AN, Harral RL, Curry VA, et al. Ciprofloxacin enhances the stimulation of matrix metalloproteinase 3 expression by interleukin -1 beta in human tendon derived cells. Arth Rehum 2002;46(11):3034-40.
Burrage PS, Mix KS, Brinckerhoff CE. Matrix metalloproteinases role in arthritis. Front Biosc 2006;11:529-43.
Rengel Y, Ospelt C, Gay S. Proteinases in the joint. linical relevance of proteinases in joint destruction. Arth Res Ther 2007;9(5):221-6.
Yabe K, Murakami Y, Nishida S, et al. A non arthropathic dose and its disposition following repeated oral administeration of ofloxacin to juvenile dogs. J Vet Med Sci 2001;63(8):867-72.